Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Endocrinología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
RIFTOS MKI - Radioactive Iodine reFractory Asymptomatic Patients in Differentiated Thyroid Cancer - an Observational Study to Assess the Use of Multikinase Inhibitors
OBSERVATIONAL
Inicio: 8 de abr de 2015
ID: NCT02303444
Reclutando
Fase 3
ClinicalTrials.gov
AN INTERVENTIONAL, OPEN-LABEL, RANDOMIZED, MULTICENTER PHASE 3 STUDY OF PF-07220060 PLUS LETROZOLE COMPARED TO CDK4/6 INHIBITOR PLUS LETROZOLE IN PARTICIPANTS OVER 18 YEARS OF AGE WITH HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE ADVANCED/METASTATIC BREAST CANCER WHO HAVE NOT RECEIVED ANY PRIOR SYSTEMIC ANTICANCER TREATMENT FOR ADVANCED/METASTATIC DISEASE (FOURLIGHT-3)
INTERVENTIONAL
Inicio: 6 de ene de 2025
ID: NCT06760637
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Parallel-Design, Open-Label, Randomized Controlled Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Glargine in Adults With Type 2 Diabetes on Multiple Daily Injections
INTERVENTIONAL
Inicio: 11 de ago de 2022
ID: NCT05462756
Completado
Fase 2
ClinicalTrials.gov
A Study to Learn How Well the Drug Larotrectinib Works in Adults With Different Solid Cancers With a Change in the Genes Called NTRK Fusion
INTERVENTIONAL
Inicio: 30 de sept de 2015
ID: NCT02576431
Reclutando
Fase 3
ClinicalTrials.gov
A Master Protocol for Phase 3 Randomized, Double-Blind, Placebo-Controlled Studies to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Osteoarthritis Knee Pain, and Obesity or Overweight (ENLIGHTEN-4)
INTERVENTIONAL
Inicio: 9 de feb de 2026
ID: NCT07353931
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) When Used in Combination With Insulin in Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de feb de 2006
ID: NCT00286429
Completado
Fase 3
ClinicalTrials.gov
Phase 2/3, Randomized, Double-blind, Placebo- and Active Comparator-controlled, Parallel, Multicenter Study to Determine Safety and Efficacy of Metaglidasen in Treatment of Type 2 Diabetes Suboptimally Controlled on Insulin
INTERVENTIONAL
Inicio: 1 de may de 2006
ID: NCT00353587
Completado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes
INTERVENTIONAL
Inicio: 27 de may de 2019
ID: NCT03952143
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-875 25 mg and 50 mg Compared to Glimepiride When Used in Combination With Metformin in Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de ene de 2012
ID: NCT01481116
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Open-Label Study of Once Daily LY3502970 Compared With Insulin Glargine in Adult Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
INTERVENTIONAL
Inicio: 3 de abr de 2023
ID: NCT05803421
Retirado
ClinicalTrials.gov
A 6-Month, Randomized Study to Evaluate the Efficacy of a Web-based Lifestyle Modification Program With and Without Telephone Counseling Support
INTERVENTIONAL
Inicio: 1 de ago de 2012
ID: NCT01664026
Completado
Fase 3
ClinicalTrials.gov
A 4-Week, Multicenter, Randomized, Double-Blind, Phase 3b Trial to Evaluate the Efficacy of Saxagliptin in Combination With Metformin XR 1500 mg Versus Up-titrated Metformin XR to 2000 mg in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise and a Stable Dose of Metformin XR 1500 mg
INTERVENTIONAL
Inicio: 1 de ago de 2009
ID: NCT00918138
Completado
Fase 3
ClinicalTrials.gov
"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial to Evaluate the Efficacy and Safety of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone"
INTERVENTIONAL
Inicio: 1 de ago de 2005
ID: NCT00121667
Completado
Fase 2
ClinicalTrials.gov
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de jun de 2010
ID: NCT01149421
Terminado
Fase 3
ClinicalTrials.gov
A Multi-center, Phase 3b, Stratified, Randomized, Open-label Clinical Trial to Evaluate the Efficacy of Intensive Apidra®/Lantus® Therapy vs Sliding Scale Insulin on Infarct Size in Hyperglycemic Subjects With Anterior STEMI (ST Elevation Myocardial Infarction) Undergoing PCI (Percutaneous Coronary Intervention)
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00670228
Completado
Fase 3
ClinicalTrials.gov
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
INTERVENTIONAL
Inicio: 29 de may de 2020
ID: NCT04255433
Por invitación
ClinicalTrials.gov
EuroSIDA Prospective Observational Cohort Study on Clinical and Virological Outcome of European Patients Infected With HIV
OBSERVATIONAL
Inicio: 1 de ene de 1994
ID: NCT02699736
Reclutando
Fase 3
ClinicalTrials.gov
A Randomised, Open-Label, Phase III Study of Saruparib (AZD5305) Plus Camizestrant Compared With Physician's Choice CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant for the First-Line Treatment of Patients With BRCA1, BRCA2, or PALB2 Mutations and Hormone Receptor Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified) Advanced Breast Cancer (EvoPAR-Breast01)
INTERVENTIONAL
Inicio: 1 de ago de 2024
ID: NCT06380751
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of Oral GW677954 as a Monotherapy for 12 Weeks Duration in Patients With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de sept de 2005
ID: NCT00196989
Reclutando
Fase 3
ClinicalTrials.gov
Phase 3, Randomized, Open-label, Controlled, Multiple Dose, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Etelcalcetide in Pediatric Subjects 28 Days to < 18 Years of Age With Secondary Hyperparathyroidism and Chronic Kidney Disease Receiving Maintenance Hemodialysis
INTERVENTIONAL
Inicio: 29 de abr de 2019
ID: NCT03633708
Anterior
1
...
29
30
31
...
434
Siguiente
Filtros